Dermatoscope Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Dermatoscope Market Size

Dermatoscope Market size is poised for substantial growth between 2024 and 2032, primarily due to the increasing prevalence of skin cancer. The Skin Cancer Foundation report of 2024 states that one in five U.S. citizens will be diagnosed with skin cancer by the age of 70.
 

Dermatoscopy tests are gaining momentum among end-users for their ability to evaluate both amelanotic and pigmented skin injuries. Using a dermatoscope, these tests can differentiate between malignant and benign tumors. Skin disorders like rosacea, psoriasis, and eczema are on the rise globally, with 1 million Canadians affected by psoriasis annually, according to the Canadian Dermatology Association, further fueling the demand for dermatoscope.
 

Dermatoscope Market Trends

The use of dermatoscopes in diagnosing various cancers, including melanoma, is becoming widespread. The increasing awareness of the significance of early cancer diagnosis and treatment is positively influencing the industry. With the increasing integration of technology in healthcare, there is a notable trend towards the adoption of telehealth solutions. The convenience and accessibility offered by telehealth services have gained significant traction, especially with the global events that have highlighted the importance of remote healthcare delivery. This trend is likely to persist as consumers seek more flexible and convenient ways to access medical consultations, monitor health conditions, and receive timely advice from healthcare professionals.
 

Dermatoscope Market Analysis

Based on products, hybrid dermatoscope segment is expected to exhibit a noteworthy CAGR due to the strong demand for technologies enhancing the visualization of pigment and vascular structures. The prevalence of pigment-related disorders worldwide is contributing to increased product usage.
 

According to recent study by Living Dappled, vitiligo affects nearly 1% of the global population and as of May 2023, nearly 70 million people were affected. This has prompted medical device manufacturing companies to develop advanced products, driving the adoption of hybrid dermatoscopes for more accurate diagnoses.
 

The dermatoscope market from handheld dermatoscope segment is expected to hold a substantial market share by 2032, driven by the growing incidence of skin cancers such as basal and squamous cell carcinomas. The convenience, high-quality visualizations, cost-effectiveness, and smartphone connectivity of handheld dermatoscopes are key factors contributing to their increased usage among dermatologists.
 

North America dermatoscope market is projected to experience commendable growth through 2032, fueled by a surge in skin diseases and substantial investments in expanding healthcare infrastructure. The prevalence of scabies and fungal infections in the U.S. and Canada is expected to accelerate the deployment of dermatoscopes. The focus on early detection and diagnosis of skin disorders and cancers, along with the region's commitment to addressing the escalating healthcare challenges and enhancing diagnostic capabilities is favoring the overall advancement of the dermatoscope industry in North America.
 

Dermatoscope Market Share

Some of the prominent dermatoscope industry players include:

• Heine Optotechnik
• Optilia Instruments AB
• AMD Global Telemedicine Inc.
• Canfield Scientific Inc.
• Welch Allyn
• 3Gen
• FotoFinder Systems Inc.
• Caliber Imaging & Diagnostics
• Firefly Global
• ILLUCO Corporation Ltd.
   

These companies are implementing various corporate strategies such as product launches, mergers & acquisitions, R&D activities, and technological advancements to strengthen their market positions.
 

Dermatoscope Industry News

• In December 2021, Canfield Scientific Inc. acquired Medici Medical s.r.l. to launch its world-class medical dermatology education program.

What Information does this report contain?